Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Midtfyns Fysioterapi Autoriserede Fysioterapeuter ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.8% 5.3% 4.7% 4.2% 3.1% 2.7% 9.4% 9.4%   Credit score (0-100)   46 43 45 47 56 59 26 26   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   638 1,337 1,328 1,527 1,827 1,913 0.0 0.0   EBITDA   159 204 185 234 385 382 0.0 0.0   EBIT   65.3 75.1 53.9 95.8 237 234 0.0 0.0   Pre-tax profit (PTP)   14.4 20.7 4.3 51.6 200.5 208.1 0.0 0.0   Net earnings   6.8 15.8 3.1 40.3 156.4 159.5 0.0 0.0   Pre-tax profit without non-rec. items   14.4 20.7 4.3 51.6 201 208 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   108 115 109 162 128 94.8 0.0 0.0   Shareholders equity total   66.8 82.6 85.7 126 232 242 42.0 42.0   Interest-bearing liabilities   1,102 994 894 789 678 563 441 441   Balance sheet total (assets)   1,268 1,290 1,282 1,222 1,172 1,087 483 483   Net Debt   1,093 880 730 709 402 196 441 441     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   638 1,337 1,328 1,527 1,827 1,913 0.0 0.0   Gross profit growth   0.0% 109.6% -0.6% 15.0% 19.7% 4.7% -100.0% 0.0%   Employees   2 2 3 4 3 3 0 0   Employee growth %   0.0% 0.0% 50.0% 33.3% -25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,268 1,290 1,282 1,222 1,172 1,087 483 483   Balance sheet change%   0.0% 1.7% -0.6% -4.6% -4.2% -7.3% -55.5% 0.0%   Added value   159.3 203.9 184.8 234.3 375.9 381.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,065 -235 -251 -198 -295 -295 -95 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.2% 5.6% 4.1% 6.3% 13.0% 12.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.2% 5.9% 4.2% 7.7% 19.9% 21.2% 0.0% 0.0%   ROI %   5.6% 6.6% 5.2% 9.9% 24.8% 25.7% 0.0% 0.0%   ROE %   10.2% 21.2% 3.7% 38.1% 87.3% 67.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.3% 6.4% 6.7% 10.3% 19.8% 22.3% 8.7% 8.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   685.8% 431.4% 395.1% 302.7% 104.4% 51.3% 0.0% 0.0%   Gearing %   1,649.8% 1,202.8% 1,042.7% 625.7% 291.9% 232.4% 1,049.9% 1,049.9%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.2% 5.2% 5.3% 5.3% 5.1% 5.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.7 0.8 0.8 1.2 1.4 0.0 0.0   Current Ratio   0.4 0.7 0.8 0.8 1.2 1.4 0.0 0.0   Cash and cash equivalent   9.4 114.0 163.7 79.6 276.3 366.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -155.1 -82.1 -68.4 -62.1 83.5 136.4 -220.5 -220.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   80 102 62 59 125 127 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   80 102 62 59 128 127 0 0   EBIT / employee   33 38 18 24 79 78 0 0   Net earnings / employee   3 8 1 10 52 53 0 0